Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 12 studies | 25% ± 7% | |
| classical monocyte | 11 studies | 25% ± 7% | |
| conventional dendritic cell | 9 studies | 31% ± 13% | |
| non-classical monocyte | 9 studies | 26% ± 9% | |
| pericyte | 6 studies | 22% ± 8% | |
| fibroblast | 5 studies | 23% ± 8% | |
| monocyte | 4 studies | 22% ± 2% | |
| dendritic cell | 4 studies | 21% ± 1% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 5% | |
| endothelial cell of vascular tree | 4 studies | 28% ± 7% | |
| endothelial cell | 4 studies | 23% ± 7% | |
| smooth muscle cell | 4 studies | 23% ± 4% | |
| plasmacytoid dendritic cell | 4 studies | 23% ± 5% | |
| regulatory T cell | 4 studies | 25% ± 11% | |
| myofibroblast cell | 3 studies | 20% ± 3% | |
| secretory cell | 3 studies | 26% ± 9% | |
| myeloid cell | 3 studies | 31% ± 9% | |
| connective tissue cell | 3 studies | 22% ± 8% | |
| CD4-positive, alpha-beta T cell | 3 studies | 18% ± 5% |
Insufficient scRNA-seq data for expression of GNG10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 1358.63 | 966 / 966 | 27% | 1.00 | 142 / 527 |
| stomach | 100% | 1042.16 | 359 / 359 | 16% | 0.64 | 47 / 286 |
| bladder | 100% | 1569.90 | 21 / 21 | 13% | 0.59 | 67 / 504 |
| adrenal gland | 100% | 1863.24 | 258 / 258 | 8% | 0.09 | 18 / 230 |
| brain | 100% | 1519.76 | 2637 / 2642 | 4% | 0.05 | 28 / 705 |
| prostate | 100% | 1652.43 | 245 / 245 | 3% | 0.05 | 16 / 502 |
| uterus | 100% | 1335.78 | 170 / 170 | 2% | 0.03 | 7 / 459 |
| ovary | 100% | 954.52 | 180 / 180 | 1% | 0.01 | 4 / 430 |
| kidney | 100% | 1265.17 | 89 / 89 | 0% | 0.00 | 4 / 901 |
| lung | 100% | 1710.13 | 576 / 578 | 1% | 0.01 | 9 / 1155 |
| thymus | 100% | 1323.15 | 653 / 653 | 0% | 0.00 | 1 / 605 |
| breast | 100% | 1703.01 | 459 / 459 | 0% | 0.00 | 1 / 1118 |
| adipose | 100% | 2015.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| liver | 100% | 700.07 | 226 / 226 | 0% | 0 | 0 / 406 |
| spleen | 100% | 1731.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 100% | 1147.90 | 1444 / 1445 | 0% | 0 | 0 / 183 |
| blood vessel | 100% | 1729.82 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 1001.49 | 836 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 557.26 | 767 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 2709.26 | 884 / 929 | 0% | 0 | 0 / 0 |
| pancreas | 91% | 486.19 | 299 / 328 | 0% | 0 | 0 / 178 |
| skin | 88% | 1170.64 | 1592 / 1809 | 0% | 0.00 | 2 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0005834 | Cellular component | heterotrimeric G-protein complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031681 | Molecular function | G-protein beta-subunit binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | GNG10 |
| Protein name | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 |
| Synonyms | GNGT10 |
| Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. Interacts with beta-1 and beta-2, but not with beta-3. |
| Accessions | P50151 ENST00000374293.5 |